AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 78 filers reported holding AVEO PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.73 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q2 2021 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q1 2021 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 6 | -90.8% | 0.00% | – |
| Q4 2019 | $0 | – | 65 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | – | 65 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | – | 65 | 0.0% | 0.00% | – |
| Q1 2019 | $0 | – | 65 | 0.0% | 0.00% | – |
| Q4 2018 | $0 | – | 65 | 0.0% | 0.00% | – |
| Q3 2018 | $0 | – | 65 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | – | 65 | 0.0% | 0.00% | – |
| Q1 2018 | $0 | – | 65 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 20,896,038 | $33,434,000 | 1.33% |
| X-Square Capital, LLC | 270,680 | $433,000 | 0.34% |
| Granahan Investment Management | 2,508,261 | $4,013,000 | 0.28% |
| 683 Capital Management, LLC | 1,875,000 | $3,000,000 | 0.18% |
| New Leaf Venture Partners, L.L.C. | 402,118 | $643,000 | 0.18% |
| Caption Management, LLC | 855,000 | $1,366,000 | 0.11% |
| Private Portfolio Partners LLC | 51,000 | $82,000 | 0.05% |
| Evercore Wealth Management, LLC | 418,414 | $669,000 | 0.02% |
| Fosun International Ltd | 206,491 | $335,000 | 0.02% |
| EXCALIBUR MANAGEMENT CORP | 11,000 | $18,000 | 0.02% |